Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Bjoern Suckow

Vascular Surgery Lebanon, NH Medical Doctor

NPI 1861644791 CMS profile 1014436

1 Medical Center Dr, Dartmouth Hitchcock - Vascular Surgery, Lebanon, NH 03756

Open in the dashboard

General payments

$101,138

157 records reported · program years 2019–2025

Research payments

$16,677

Paid to them · 6 records reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$561,209 paid to institutions, not to them · program years 2019–2025

Through program year 2025, Bjoern Suckow of Lebanon, NH is reported in the CMS Open Payments database as having received $101,138 across 157 general payments and $16,677 in research payments paid to them. Separately, studies naming them as principal investigator received $561,209 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 96th percentile of Vascular Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

8 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $44,406 45
2025 Research $16,677 6
2024 General $36,236 38
2023 General $2,820 14
2022 General $9,443 23
2021 General $254 2
2020 General $1,846 9
2019 General $6,134 26

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Bjoern Suckow
  • Vascular Surgery median
  • Middle half of Vascular Surgery
  • National median

In program year 2025, general payments to Bjoern Suckow were reported at $44,406. Among 3,991 Vascular Surgery profiles paid that year, the median was $924 and the middle half received between $273 and $2,636.

Show as a table
Year Bjoern Suckow Vascular Surgery median Middle half National median
2019 $6,134 $796 $226–$2,363 $163
2020 $1,846 $348 $118–$1,110 $114
2021 $254 $471 $158–$1,421 $132
2022 $9,443 $725 $222–$2,183 $149
2023 $2,820 $836 $257–$2,440 $160
2024 $36,236 $909 $252–$2,619 $164
2025 $44,406 $924 $273–$2,636 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Ge Healthcare $37,694 17 payments
  2. W. L. Gore & Associates, Inc. $21,268 45 payments
  3. Siemens Medical Solutions USA, Inc. $18,016 7 payments
  4. Endologix, Inc. $8,491 16 payments
  5. Cook Incorporated $6,177 11 payments
  6. Cook Medical LLC $5,860 38 payments
  7. Boston Scientific Corporation $1,109 11 payments
  8. Vascular Technology, Inc. $1,050 2 payments
  9. Shape Memory Medical Inc. $518 3 payments
  10. Silk Road Medical, Inc. $324 2 payments
  11. Other $631 5 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $65,270 25 payments
  2. Travel and Lodging $27,761 31 payments
  3. Food and Beverage $7,762 99 payments
  4. Honoraria $300 1 payment
  5. Education $46 1 payment
Products named General payments · program years 2019–2025
  1. Product in Development $10,611 5 payments
  2. GORE EXCLUDER Thoracoabdominal Branch Endoprosthesis $7,716 17 payments
  3. Zenith Alpha Aortic Intervention $3,137 18 payments
  4. Cook Medical Zenith $2,859 4 payments
  5. ZENITH ALPHA Aortic Intervention $2,612 4 payments
  6. Allia $2,028 2 payments
  7. TAG Thoracic Endoprosthesis $2,005 7 payments
  8. Cook Medical Aortic Intervention $1,521 9 payments
  9. Cook Medical AAA $587 1 payment
  10. IMPEDE EMBOLIZATION PLUG $518 3 payments
  11. Other $5,088 57 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Cook Research Incorporated $16,677 6 payments

Prescribing to Medicare patients

Part D · data year 2024 · 4 drugs

Part D claims

121

Median for Vascular Surgery: 122

Drug cost

$49,298

Median for Vascular Surgery: $14,135

Branded share of claims

90.9%

Median for Vascular Surgery: 71%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Eliquis Apixaban Brand 30 $25,874
Xarelto Rivaroxaban Brand 25 $22,392
Clopidogrel Clopidogrel Bisulfate Brand 55 $647
Cilostazol Generic 11 $385

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 3,087 Part D prescribers listed as Vascular Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 97 billing codes

Paid by Medicare

$152,573

Medicare's payments for the services billed

Medicare patients

578

Average age 75

Services billed

1,006

220 women, 358 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Ischemic heart disease 44%
Arthritis 42%
Diabetes 31%
Chronic kidney disease 29%
COPD 29%
Heart failure 25%
Atrial fibrillation 25%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

163 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record